Trade this ETF at your broker
Index | MSCI UK (USD Hedged) |
Investment focus | Equity, United Kingdom |
Fund size | EUR 16 m |
Total expense ratio | 0.23% p.a. |
Replication | Physical (Full replication) |
Legal structure | ETF |
Strategy risk | Long-only |
Sustainability | No |
Fund currency | USD |
Currency risk | Currency hedged |
Volatility 1 year (in EUR) | 10.98% |
Inception/ Listing Date | 15 November 2023 |
Distribution policy | Distributing |
Distribution frequency | Semi annually |
Fund domicile | Luxembourg |
Fund Provider | UBS ETF |
Fund Structure | Company With Variable Capital (SICAV) |
UCITS compliance | Yes |
Administrator | State Street Bank International GmbH, Luxembourg Branch |
Investment Advisor | |
Custodian Bank | State Street Bank International GmbH, Luxembourg Branch |
Revision Company | Ernst & Young, société anonyme |
Fiscal Year End | 31 December |
Swiss representative | UBS Fund Management (Switzerland) AG |
Swiss paying agent | UBS Switzerland AG |
Tax data | Bundesanzeiger | |
Germany | Unknown | |
Switzerland | ESTV Reporting | |
Austria | Tax Reporting Fund | |
UK | UK Reporting |
Indextype | - |
Swap counterparty | - |
Collateral manager | |
Securities lending | Yes |
Securities lending counterparty | ABN AMRO Bank N.V.|Bank of Nova Scotia (London Branch)|Barclays Bank plc|Barclays Capital Securities Limited|BNP Paribas (London Branch)|BNP Paribas SA|Citigroup Global Markets Limited|Commerzbank AG|Commerzbank AG (London Branch)|Credit Suisse Securities (Europe) Limited|Deutsche Bank AG|Deutsche Bank AG (London Branch)|Goldman Sachs International|HSBC Bank plc|ING Bank N.V.|ING Bank N.V. (London Branch)|JP Morgan Securities PLC|MacQuarie Bank Ltd. (London Branch)|Merrill Lynch International|Morgan Stanley Morgan Stanley & Co. International plc|SEB AG (Frankfurt Branch)|Skandinaviska Enskilda Banken|Societe Generale SA|Societe Generale SA (London Branch)|State Street Bank International GmbH (London Branch) |
AstraZeneca PLC | 9.30% |
Shell Plc | 7.90% |
HSBC Holdings Plc | 6.41% |
Unilever Plc | 6.25% |
RELX | 3.39% |
BP Plc | 3.36% |
GSK Plc | 3.25% |
Rio Tinto Plc | 3.09% |
Diageo Plc | 3.00% |
British American Tobacco plc | 2.81% |
United Kingdom | 92.63% |
Switzerland | 2.59% |
Ireland | 2.13% |
Other | 2.65% |
Financials | 18.48% |
Consumer Staples | 18.35% |
Health Care | 13.23% |
Industrials | 13.20% |
Other | 36.74% |
Broker | Rating | Order fee | ETF savings plans | |
---|---|---|---|---|
0.99€ | 2593 | View offer* | ||
0.00€ | 1087 | View offer* | ||
0.00€ | 897 | View offer* | ||
5.90€ | 1706 | View offer* | ||
6.15€ | 1084 | View offer* |
YTD | +13.17% |
1 month | -0.39% |
3 months | +1.59% |
6 months | +0.00% |
1 year | +14.90% |
3 years | - |
5 years | - |
Since inception (MAX) | +15.66% |
2023 | - |
2022 | - |
2021 | - |
2020 | - |
Current dividend yield | 2.85% |
Dividends (last 12 months) | EUR 0.15 |
Period | Dividend in EUR | Dividend yield in % |
---|---|---|
1 Year | EUR 0.15 | 3.20% |
Volatility 1 year | 10.98% |
Volatility 3 years | - |
Volatility 5 years | - |
Return per risk 1 year | 1.35 |
Return per risk 3 years | - |
Return per risk 5 years | - |
Maximum drawdown 1 year | -6.07% |
Maximum drawdown 3 years | - |
Maximum drawdown 5 years | - |
Maximum drawdown since inception | -6.07% |
Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
---|---|---|---|---|---|
SIX Swiss Exchange | USD | UKUSDD | UKUSDD SW UKUSDDIV | UKUSDD.S UKUSDDUSDINAV=SOLA |
Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
---|---|---|---|---|
iShares Core FTSE 100 UCITS ETF (Dist) | 13,506 | 0.07% p.a. | Distributing | Full replication |
Vanguard FTSE 100 UCITS ETF Distributing | 4,361 | 0.09% p.a. | Distributing | Full replication |
iShares Core FTSE 100 UCITS ETF GBP (Acc) | 2,633 | 0.07% p.a. | Accumulating | Full replication |
Vanguard FTSE 250 UCITS ETF Distributing | 2,439 | 0.10% p.a. | Distributing | Full replication |
Vanguard FTSE 100 UCITS ETF (GBP) Accumulating | 1,612 | 0.09% p.a. | Accumulating | Full replication |